Health Boards
Thu-13-01-2022, 14:27 PM
Update: The National Institute for Health and Care Excellence (NICE) has recommended Rinvoq (upadacitinib) as a treatment option for certain patients with active psoriatic arthritis (PsA) in England and Wales.
|
Rinvoq goes for psoriatic arthritis approval
|
|
« Next Oldest | Next Newest »
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
|
Psoriatic arthritis and GLP-1RA therapy | Fred | 7 | 782 |
Fri-10-04-2026, 16:32 PM Last Post: mataribot |
|
|
Radiographic structural damage & psoriatic arthritis | Fred | 0 | 407 |
Sat-21-03-2026, 13:21 PM Last Post: Fred |
|
|
Icotrokinra seeks approval for psoriasis | Fred | 7 | 3,127 |
Fri-20-03-2026, 06:30 AM Last Post: mataribot |
|
|
Bimzelx vs Skyrizi for psoriatic arthritis | Fred | 4 | 939 |
Tue-17-03-2026, 13:01 PM Last Post: Fred |
|
|
Sotyktu accepted for review in psoriatic arthritis | Fred | 3 | 2,020 |
Fri-13-03-2026, 13:33 PM Last Post: Fred |
Users browsing this thread: 1 Guest(s)